Prospects for nanomedicine in treating age-related macular degeneration.

Polyion complex (PIC) micelles have a size range of tens of nanometers formed through electrostatic interaction. In experimental choroidal neovascularization (CNV) in rats, the PIC micelle accumulates to the CNV lesions and is retained. PIC micelles can be used for effective drug delivery to CNV. A novel dendritic photosensitizer encapsulated by a polymeric-micelle formulation was employed for an effective photodynamic therapy for age-related macular degeneration. With its highly selective accumulation on experimental CNV lesions, this treatment resulted in a remarkably efficacious CNV occlusion with minimal unfavorable phototoxicity. Gene therapy is a promising approach to treat age-related macular degeneration. A ternary complex, composed of a core containing DNA packaged with cationic peptides and enveloped in the anionic dendrimer phthalocyanine, has been developed, which provides the photosensitizing action. Subconjunctival injection of the ternary complex followed by laser irradiation resulted in transgene expression only in the laser-irradiated site in rats.

[1]  K. Berg,et al.  Photochemical transfection: a new technology for light-induced, site-directed gene delivery. , 2000, Human gene therapy.

[2]  Kristian Berg,et al.  Photochemical internalisation in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[3]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[4]  K. Kataoka,et al.  Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  R. Müller,et al.  Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.

[6]  Yuichi Yamasaki,et al.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. , 2004, Journal of the American Chemical Society.

[7]  F. Ferris,et al.  Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.

[8]  K. Leong,et al.  Multifunctional nanorods for gene delivery , 2003, Nature materials.

[9]  John I. Loewenstein,et al.  Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. , 2003, Ophthalmology.

[10]  K. Kataoka,et al.  Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats , 2004, FEBS letters.

[11]  K. Kataoka,et al.  Polyion complex micelles as vectors in gene therapy – pharmacokinetics and in vivo gene transfer , 2002, Gene Therapy.

[12]  R. Obata,et al.  Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase. , 2003, Investigative ophthalmology & visual science.

[13]  Atsushi Harada,et al.  Formation of Polyion Complex Micelles in an Aqueous Milieu from a Pair of Oppositely-Charged Block Copolymers with Poly(ethylene glycol) Segments , 1995 .

[14]  Kazunori Kataoka,et al.  Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer , 2005, Nature materials.

[15]  Stephen P. Daiger,et al.  Was the Human Genome Project Worth the Effort? , 2005, Science.

[16]  Jindrich Kopecek,et al.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. , 2002, Advanced drug delivery reviews.

[17]  Kazunori Kataoka,et al.  Block copolymer micelles for delivery of gene and related compounds. , 2002, Advanced drug delivery reviews.

[18]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[19]  Y. Sugiyama,et al.  Cisplatin-Loaded Polymer-Metal Complex Micelle with Time-Modulated Decaying Property as a Novel Drug Delivery System , 2001, Pharmaceutical Research.

[20]  P. Campochiaro,et al.  Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. , 2006, Human gene therapy.

[21]  K. Kataoka,et al.  Pronounced activity of enzymes through the incorporation into the core of polyion complex micelles made from charged block copolymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[22]  P. Campochiaro,et al.  Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1 , 2006, Gene Therapy.

[23]  D. Bull,et al.  Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer , 2003, Gene Therapy.

[24]  Ernst Wagner,et al.  Targeting tumors with non-viral gene delivery systems. , 2002, Drug discovery today.

[25]  Y. Ikada,et al.  Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization. , 1999, Investigative ophthalmology & visual science.

[26]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[27]  J. P. Sy,et al.  Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. , 2006, Ophthalmology.

[28]  C. Hyde,et al.  Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review , 2004, British Journal of Ophthalmology.

[29]  T. Aida,et al.  Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. , 2005, Nano letters.

[30]  R. Obata,et al.  Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. , 2002, Investigative ophthalmology & visual science.

[31]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Y. Tabata,et al.  Drug targeting to choroidal neovascularization. , 2001, Advanced drug delivery reviews.